# PHAGE THERAPY - CRISPR-Armed Phages & Therapeutic Applications
# Version: 1.0.0 | Domain: VIRUSES (Lateral)
# Based on: SNIPR001 Phase 1b (2025), LBP-EC01 ELIMINATE trial (2025)

perspective: phage_therapy
version: "1.0.0"

phage_name:
  # morph: text
  ""

# THERAPEUTIC DEVELOPMENT (2025)
clinical_trial_status:
  # morph: badge
  # preclinical | phase_1 | phase_2 | phase_3 | approved
  status: ""
  variant: ""

crispr_armed_phage:
  # morph: boolean
  # CAP - SNIPR001 approach (2025)
  false

crispr_system:
  # morph: badge
  # Cas9 | Cas3 | Cas12 | none
  status: ""
  variant: ""

target_bacteria:
  # morph: list
  # E. coli | P. aeruginosa | S. aureus
  - ""

antibiotic_resistance_target:
  # morph: list
  # fluoroquinolone | carbapenem | methicillin
  - ""

# PRECISION TARGETING
microbiome_preservation:
  # morph: boolean
  # selective vs broad-spectrum
  false

off_target_effects:
  # morph: rating
  # lower = better
  rating: 0
  max: 10

# ENGINEERING (2025)
phage_engineering_methods:
  # morph: list
  # CRISPR_editing | phage_display | mutagenesis | retrons | rebooting
  - ""

synthetic_biology_modifications:
  # morph: list
  - ""

# THERAPEUTIC EFFICACY
bacterial_load_reduction:
  # morph: gauge
  # % reduction
  value: 0
  min: 0
  max: 100
  unit: "%"

resistance_evolution_risk:
  # morph: rating
  rating: 0
  max: 10

# DELIVERY & FORMULATION
administration_route:
  # morph: badge
  # oral | topical | IV | inhalation
  status: ""
  variant: ""

phage_cocktail:
  # morph: boolean
  # multiple phages
  false

phage_count_in_cocktail:
  # morph: number
  0

# CLINICAL APPLICATIONS
treatment_indication:
  # morph: list
  # UTI | wound_infection | sepsis | gut_decolonization
  - ""

combination_with_antibiotics:
  # morph: boolean
  false

# REGULATORY STATUS
regulatory_pathway:
  # morph: badge
  # investigational | compassionate_use | approved
  status: ""
  variant: ""

# DATA
data_source:
  # morph: badge
  status: ""
  variant: ""

last_updated:
  # morph: text
  ""
